SAP130 inhibitors are chemical compounds designed to target and modulate the activity of the SAP130 protein, which is a component of the splicing factor 3B subunit 3 (SF3B3) complex. This protein is integral in the regulation of RNA splicing, a critical post-transcriptional process where introns are removed, and exons are joined to form mature messenger RNA (mRNA). The proper functioning of the splicing machinery is essential for maintaining the fidelity of gene expression, as errors in splicing can lead to the production of aberrant proteins. SAP130 plays a pivotal role within this machinery, acting as a scaffold that facilitates the interaction of various splicing factors. Inhibition of SAP130 can, therefore, disrupt the normal splicing process by affecting the structural integrity or activity of the splicing complex, leading to alternative or aberrant splicing patterns.
The biochemical design of SAP130 inhibitors involves the identification and targeting of key binding sites on the SAP130 protein that are essential for its interactions with other components of the splicing machinery. These inhibitors typically operate through competitive binding, where they occupy critical regions of SAP130, preventing its association with other splicing factors. By modulating these interactions, SAP130 inhibitors offer a precise means of controlling the dynamics of RNA splicing. Understanding the structural features of both the protein and its inhibitors is essential for developing molecules with high specificity and potency. Researchers in structural biology and computational chemistry often use techniques like X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and molecular docking to elucidate the mechanisms by which these inhibitors exert their effects on SAP130 and the broader splicing machinery.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A hydroxamic acid that can inhibit class I and II HDACs. By inhibiting HDACs, TSA can indirectly impact SAP130's activity in the Sin3A-HDAC complex. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor, can impact SAP130 indirectly through its effect on the Sin3A-HDAC complex. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Inhibits class I HDACs. Its action can lead to hyperacetylation of histones, potentially affecting the function of the Sin3A-HDAC complex and thus SAP130 indirectly. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Specific inhibitor for class I HDACs. Can affect the Sin3A-HDAC complex's activity, therefore affecting SAP130. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
HDAC inhibitor, specifically classes I and II. It can influence the Sin3A-HDAC complex, impacting SAP130 indirectly. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Is selective for class I HDACs. The action of this inhibitor can indirectly affect SAP130 through the Sin3A-HDAC complex. | ||||||
PCI-34051 | 950762-95-5 | sc-364566 sc-364566A | 10 mg 100 mg | $189.00 $1671.00 | 5 | |
HDAC8-specific inhibitor. This can affect the wider HDAC community and thus impact the Sin3A-HDAC complex and SAP130 indirectly. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Inhibits classes I, II, and IV HDACs. By acting on these HDACs, it can influence the Sin3A-HDAC complex and therefore SAP130. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
Inhibits classes I and II HDACs. Its function can potentially affect SAP130 via the Sin3A-HDAC complex. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Inhibits class I HDACs, leading to hyperacetylation of histones which can impact the Sin3A-HDAC complex and thus SAP130. | ||||||